US 12208071
Glucagon receptor antagonists
granted A61KA61K31/155A61K31/185
Quick answer
US patent 12208071 (Glucagon receptor antagonists) held by Ligand Pharmaceuticals Incorporated expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/155, A61K31/185, A61K31/366, A61K31/427